The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
UAE schools and universities to resume in-person learning on Monday, May 11
Mauritania delivers message to UAE President during Abu Dhabi talks
Arab League condemns Iranian attacks on UAE, Kuwait, Qatar
UAE condemns drone attack on commercial ship in Qatari waters
Smoke in Al Jaddaf area confirmed as docked boat catching fire, no injuries
